F2 c.56G>A ;(p.C19Y)

Variant ID: 11-46740841-G-A

NM_000506.3(F2):c.56G>A;(p.C19Y)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.

The New England Journal Of Medicine
George, Lindsey A LA; Sullivan, Spencer K SK; Giermasz, Adam A; Rasko, John E J JEJ; Samelson-Jones, Benjamin J BJ; Ducore, Jonathan J; Cuker, Adam A; Sullivan, Lisa M LM; Majumdar, Suvankar S; Teitel, Jerome J; McGuinn, Catherine E CE; Ragni, Margaret V MV; Luk, Alvin Y AY; Hui, Daniel D; Wright, J Fraser JF; Chen, Yifeng Y; Liu, Yun Y; Wachtel, Katie K; Winters, Angela A; Tiefenbacher, Stefan S; Arruda, Valder R VR; van der Loo, Johannes C M JCM; Zelenaia, Olga O; Takefman, Daniel D; Carr, Marcus E ME; Couto, Linda B LB; Anguela, Xavier M XM; High, Katherine A KA
Publication Date: 2017-12-07

Variant appearance in text: F2: C19Y
PubMed Link: 29211678
Variant Present in the following documents:
  • Main text
View BVdb publication page